Basit öğe kaydını göster

dc.contributor.authorSevim, Mehmet Şahin
dc.contributor.authorSanişoğlu, Hüseyin
dc.contributor.authorTürkyılmaz, Kemal
dc.date.accessioned2020-12-19T20:05:07Z
dc.date.available2020-12-19T20:05:07Z
dc.date.issued2012
dc.identifier.citationSevim, MS., Sanişoğlu, H., Türkyılmaz, K. (2012). Intravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edema. Current Eye Research, 37(12), 1165-1170.en_US
dc.identifier.issn0271-3683
dc.identifier.issn1460-2202
dc.identifier.urihttps://doi.org/10.3109/02713683.2012.721444
dc.identifier.urihttps://hdl.handle.net/11436/3407
dc.descriptionWOS: 000311546500013en_US
dc.descriptionPubMed: 22928501en_US
dc.description.abstractPurpose: To compare the efficacy of intravitreal triamcinolone acetonide injection versus 23-gauge pars plana vitrectomy with internal limiting membrane peeling for the treatment of chronic pseudophakic cystoid macular edema (CME) after uncomplicated cataract surgery. Methods: This retrospective, comparative, consecutive case series study included 39 patients with chronic pseudophakic CME. Twenty eyes in 20 patients were treated with intravitreal triamcinolone acetonide injection (IVT group), and 19 eyes in 19 patients were treated with pars plana vitrectomy with internal limiting membrane peeling (PPV group). in both groups, complete ophthalmologic examinations were performed before and after procedures. Findings were compared between the groups. Results: Both groups experienced a significant improvement in visual acuity and macular thickness after 12 months follow-up. At months 1 and 2, the IVT group showed a significant improvement in visual acuity and a significant reduction in macular thickness compared with the PPV group (p < 0.05), but these differences were not statistically significant between the groups after the 12-month period. Conclusion: Both intravitreal steroid injection and pars plana vitrectomy with internal limiting membrane peeling had a favorable effect on visual and anatomic results in patients with chronic pseudophakic CME. However, surgical treatment had no advantage over intravitreal triamcinolone acetonide injection after 12-months follow-up.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Incen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPseudophakic Cystoid Macular Edemaen_US
dc.subjectIntravitreal Triamcinolone Acetonideen_US
dc.subjectPars Plana Vitrectomyen_US
dc.titleIntravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edemaen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorTürkyılmaz, Kemal
dc.identifier.doi10.3109/02713683.2012.721444
dc.identifier.volume37en_US
dc.identifier.issue12en_US
dc.identifier.startpage1165en_US
dc.identifier.endpage1170en_US
dc.relation.journalCurrent Eye Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster